Project Grant R03MH141504
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $157K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- This federal Project Grant award, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), will support research to characterize a genetic mouse model for a gene implicated in neurodevelopmental disorders including autism, intellectual disability, and schizophrenia. The $742,484 award, with a project period from January 13, 2025 to October 31, 2029, will fund experiments to obtain multiome single nucleus RNA-sequencing,...
- This federal Project Grant award of $136,050.00, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to investigate how a specific protein, BTBD11, regulates the function and composition of glutamatergic synapses in interneurons. The research aims to elucidate the role of BTBD11 and liquid-liquid phase separation in maintaining the unique properties of glutamatergic synapses in interneurons, which are...
- This federal Project Grant award of $692,043 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to investigate the role of presynaptic homeostatic plasticity in mental health disorders such as autism and intellectual disability. The award recipient, The Regents of the University of California, San Francisco (UCSF), will conduct research to elucidate the molecular mechanisms underlying homeostatic plasticity and...
- This Project Grant award of $3,498,931.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to comprehensively investigate the impact of loss of 100 neurodevelopmental and psychiatric disorder (NPD) genes in mice. The project, titled "Cross Scale Interrogation of NPD Genes (SING) in Mice", will utilize knockout mouse models to examine gene expression, cellular changes, neural circuits, and behaviors across multiple...
- This federal Project Grant award, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), will fund research to investigate the impact of autism spectrum disorder (ASD) genetic risk on microglia-neuronal interactions. The $165,796 award, effective November 22, 2024 through June 30, 2028, will support the use of human stem cell culture and 3D cortical spheroid models to assess how ASD genetic risk affects microglia physiology and...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $429,000 to investigate the role of synaptic adhesion molecules in guiding myelination of axons in the central nervous system. The primary objectives are to determine whether the proteins NCAM1, CADM1, and CADM4 direct the formation of myelin sheaths on specific axons, using a zebrafish model system to observe axon-myelin interactions in vivo. The...
- This federal Project Grant award of $422,280, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to identify and interrogate novel intracellular proteins that underlie the distinct nanoscopic architecture of the neurexin-1 and neurexin-3 proteins. The research aims to determine how the intrinsically monomeric neurexins are organized into discrete and homogeneous nanoclusters, which is a fundamentally...
- The National Institute of Mental Health (NIMH) awarded a 5-year, $4,925,302 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Washington University in St. Louis to conduct systematic and scalable phenotyping of over 100 mouse models for neuropsychiatric diseases. The project aims to comprehensively investigate the molecular, spatial, and behavioral impacts of genetic variants associated with conditions like autism, schizophrenia, and intellectual disability....
- This federal Project Grant award of $196,460 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is supporting research to elucidate the neural substrates underlying novelty-related social investigation behaviors in mice. The research aims to leverage in vivo recording techniques, projection-specific optogenetic stimulation, and computational approaches to determine how social recognition information encoded in the ventral...
- This $196,460 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to characterize the role of the Integrator-Z3 module in regulating neuronal differentiation. The principal investigator will conduct biochemical purification, proteomics, and RNA-sequencing analyses to investigate how the interaction between the Integrator...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $156,500.00 to Emory University to investigate the neuronal function of the zinc-finger protein ZNF185. The research aims to determine how ZNF185 regulates neural development, synaptic function, and behavior, with potential implications for understanding intellectual disability and autism spectrum disorder. The award period runs from September 1, 2025 to August 31, 2027. The research will utilize a ZNF185 knockout mouse model to examine the role of this protein in synaptic development and function, as well as its effects on brain development and behavior.
Generated 10/21/25, 5:23 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $156.5k | 8/18/25 |